Skip to main content

Researchers Identify Biomarkers for Obesity Risk in Women

Low levels of a biochemical process involved in fat breakdown predicts weight gain and metabolic complications more than a decade later.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

ISTOCK, STOCKVISUALAn impaired ability to break down fats is associated with later weight gain and metabolic disorders in women, according to a study published today (May 31) in Cell Metabolism. Researchers at the Karolinska Institute found that low levels of a biochemical process known as hormone-stimulated lipolysis were linked to increased weight and complications such as type 2 diabetes 13 years later, offering the possibility of a diagnostic test for obesity risk as well as improved interventions.

“This information could be used by clinicians to determine who would benefit the most from intensified lifestyle interventions such as physical activity, which enhances hormone-stimulated lipolysis and may therefore prevent fat accumulation and metabolic disturbances,” study coauthor Mikael Ryden says in a statement.

Ryden and his colleagues collected fat biopsies from 89 women, and followed up after an average of 13 years. The team found that, compared with women who went on to maintain a stable weight over that period, women who gained weight over the course of the study showed relatively low levels of hormone-stimulated lipolysis and low expression of genes involved in regulating fat breakdown.

The researchers also developed an algorithm to estimate the rates of hormone-stimulated lipolysis on the basis of biomarkers ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile

Related Topics

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Improving Western Blot Analysis of Biofluid Samples

Improving Western Blot Analysis of Biofluid Samples

Bio-Rad
Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter
Optimizing SV-AUC for Peptide Therapeutic Analysis

Optimizing SV-AUC for Peptide Therapeutic Analysis

​Beckman Coulter

Products

Sino Biological Logo

Sino Biological Advances AI-Designed Molecule Validation with 4RISE™

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation